US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Ben Whishaw lights up the Croisette as he joins his co
Ben Whishaw was all smiles at the world premiere of Limonov: The Ballad at the 77th annual Cannes Fi2024-05-21Ice and snow warm up winter tourism in Northeast China
Seeing an increasing number of people visiting the Polarpark since it started operating around a wee2024-05-21Beijing to host WTT China Smash in September
Beijing has won the bid for the World Table Tennis (WTT) China Smash from 2024 to 2028, with this ye2024-05-21Nagelsmann opens doors to Germany's new generation
The unveiling of Germany's UEFA 2024 Euro kits heralds a new era under coach Julian Nagelsmann,2024-05-21Russian theater director and playwright go on trial over a play authorities say justifies terrorism
TALLINN, Estonia (AP) — A Russian court on Monday opened the trial of a theater director and a playw2024-05-21A man is charged with causing a car crash that killed an on
TUCSON, Ariz. (AP) — A man has been charged with causing a car crash that killed an on-duty Tucson p2024-05-21
atest comment